Amanote Research
Register
Sign In
P3.cr-11 ROS1 Fusion and MET Amplification Dual Drive Coexistence in Lung Adenocarcinoma and Response to Crizotinib: A Case Report
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1990
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
C. Xu
W. Wang
Z. Song
Q. Zhang
W. Zhuang
Y. Chen
G. Chen
M. Fang
T. Lv
Y. Song
Publisher
Elsevier BV
Related search
P3.cr-13 Dual Drive Coexistence of EML4-ALK Fusion and TPM3-ROS1 Fusion Lung Adenocarcinoma: A Case Report
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
ROS1-ADGRG6: A Case Report of a Novel ROS1 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Crizotinib
BMC Cancer
Cancer Research
Oncology
Genetics
P3.cr-10 HIP1-ALK Fusion Variant in Non-Small-Cell Lung Cancer and Response to Crizotinib
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.cr-04 Lung Cancer With Concurrent ROS1 Rearrangement and KRAS Mutation: A Case Report
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Clinical Activity of Crizotinib in Lung Adenocarcinoma Harboring a Rare ZCCHC8-ROS1 Fusion
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.cr-09 MET-UBE2H Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma" With "MET Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Rapid Response of Brain Metastasis to Crizotinib in a Patient With KLC1-ALK Fusion and MET Gene Amplification Positive Non-Small Cell Lung Cancer: A Case Report
Cancer Biology and Medicine
Cancer Research
Oncology
A Novel EML6-ALK FBXO11-ALK Double Fusion Variant in Lung Adenocarcinoma and Response to Crizotinib
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.01-104 EGFR-RAD51 Fusion Variant in Lung Adenocarcinoma and Response to Erlotinib: A Case Report
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
